Profile
Dr Lim Ee Wei is a Senior Consultant at the Department of Neurology, National Neuroscience Institute. Dr Lim received her medical degree from University of Malaya in 2004 and then MRCP (UK) in 2009. She received her Neurology specialist training in the Department of Neurology, National Neuroscience Institute. Dr Lim is currently having her fellowship training in King’s College Hospital London in Movement Disorders. Her philosophy in daily practice as a doctor is doing good, avoiding harm and comforting always.
Education
- Advanced Specialist Training in Neurology, 2014
- MRCP (United Kingdom), 2009
- MBBS University of Malaya, 2004
View More +
Professional Appointments and Committee Memberships
- Senior Consultant, Department of Neurology, National Neuroscience Institute (NNI@SGH)
- Senior Consultant, Department of Neurology, National Neuroscience Institute (NNI@SKH)
- Clinical Teacher in Neurology Clerkship, Duke-NUS
- Clinical Lecturer, NUS Yong Loo Lin School of Medicine
- Clinical Teacher, Lee Kong Chian School of Medicine
- Member of the Intensive Care Unit Committee, 2014 - early 2017
View More +
Awards
- FY 2016 SingHealth Health Manpower Development Plan (HMDP) Fellowships Award
- Service With A Heart Award, May 2015
- Singapore Health Quality Service Award Silver Award, April 2011 to March 2012
View More +
Research Interests
- Parkinson's Disease
- Movement Disorders
View More +
Publications
- EW Lim, CW Yip. Anti-N-methyl-D-aspartate receptor encephalitis associated with hepatic neuroendocrine carcinoma: a case report J Clin Neurosci. 2017 Jul;41:70-72. DOI: 10.1016/j.jocn.2017.02.038. Epud 2017 Mar 2.
- EW Lim, YH Pang, Pavanni Ratnagopal. Interval form of carbon monoxide intoxication. Clin Med Img Lib 2017, 3:062 DOI: 10.23937/2474-3682/510062.
View More +
Research Trials
- Long Term effects of irradiation therapy for nasopharyngeal carcinoma on carotid artery stenosis-Establishing evidence for screening and prevention of stroke
- Case Control Diffusion Tensor Imaging (DTI) Study of The Facial Nerve in Hemifacial Spasm Patients
- 2014/00712: Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate (110 mg or 150 mg, oral b.i.d.) versus acetylsalicylic acid (100 mg oral q.d.) in patients with Embolic Stroke of Undetermined Source (RESPECT ESUS)
- Pilot randomized controlled study of the efficacy of spinal magnetic stimulation for refractory constipation
View More +
